Board to review Q2 results and consider rights issue

Net loss reportedEBITDA margin compressionExceptional itemResults View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹82.55

prior close

₹82.32

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.5%+4.6% vs market

Specialty Chemicals peers, median of 97sector-2.0%+4.1% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 4.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.2

15m

-0.3

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1-2.5+4.6-2.0+4.1

Next day

+7.8-1.1+8.9+0.0+7.8

+10.9-0.8+11.7-0.2+11.1

-9.1+1.3-10.4+0.8-9.9

-8.0+2.5-10.4+1.9-9.9

-7.7pendingpending+0.4-8.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 97Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board will meet on November 3, 2026 to approve unaudited standalone and consolidated results for the quarter and six months ended September 30, 2026. It will also consider raising funds through a rights issue of equity shares or another security, subject to approvals. No financial figures or fundraising terms were disclosed.

Likely market impact

The results may move the share price, while a possible rights issue could strengthen funding but dilute existing shareholders. Terms and performance are not yet known.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹491.5 Cr	₹459.8 Cr	+6.9%
Operating profit	−₹38.28 Cr	−₹4.32 Cr	loss widened
Profit after tax	−₹29.70 Cr	−₹14.95 Cr	loss widened
EBITDA margin	0.1%	7.3%	−7.2 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.